Frederick, MD, United States of America

Tatiana Guerassina

This inventor holds 1 USPTO granted patent. Top assignee: Sequoia Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatiana Guerassina. Retrieved from https://idiyas.com/inventor/tatiana-guerassina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tatiana Guerassina: Innovator in Retroviral Protease Inhibitors

Introduction

Tatiana Guerassina is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for HIV infections.

Latest Patents

Tatiana holds a patent for "Resistance-repellent retroviral protease inhibitors." This patent encompasses resistance-repellent and multidrug-resistant retroviral protease inhibitors. The pharmaceutical composition includes these compounds and outlines methods for using them to treat HIV infections in mammals.

Career Highlights

Tatiana is currently employed at Sequoia Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work focuses on creating effective treatments that address the challenges posed by drug resistance in retroviral infections.

Collaborations

Tatiana collaborates with Michael Eissenstat, contributing to the innovative research environment at Sequoia Pharmaceuticals, Inc.

Conclusion

Tatiana Guerassina's work in developing resistance-repellent retroviral protease inhibitors showcases her dedication to improving treatment options for HIV infections. Her contributions to the pharmaceutical industry are invaluable and highlight the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…